Materias dentro de su búsqueda.
Mostrando 1,101 - 1,120 Resultados de 24,879 Para Buscar '".eu"', tiempo de consulta: 0.20s Limitar resultados
  1. 1101
    “…Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on shrimp peptide concentrate as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is a peptide mixture obtained by an enzymatic proteolysis from northern shrimp (Pandalus borealis) shells and heads. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Safety of shrimp peptide concentrate as a novel food pursuant to Regulation (EU) 2015/2283
  2. 1102
    “…Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver a scientific opinion on a mixture of xylo‐oligosaccharides (XOS) as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is obtained from corncobs (Zea mays subsp. mays) via enzyme‐catalysed hydrolysis and subsequent purification. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Safety of xylo‐oligosaccharides (XOS) as a novel food pursuant to Regulation (EU) 2015/2283
  3. 1103
    Materias: “…EU‐FORA: Series 2…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Assessment of the endocrine disrupting properties of Bisphenol AF according to the EU criteria and ECHA/EFSA guidance
  4. 1104
    “…This review addresses the available legislation on nanopharmaceuticals within the European Union (EU), the GMP that should be followed for their production, and the current challenges encountered in clinical trials of these new formulations. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU
  5. 1105
    por Lamy, Marie, Phua, Kai Hong
    Publicado 2012
    “…Through a comparative study with the regional mechanisms of the European Union (EU) for health cooperation, we look at how ASEAN could maximize its potential as a global health actor. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Southeast Asian cooperation in health: a comparative perspective on regional health governance in ASEAN and the EU
  6. 1106
    “…Due to its high economic importance and high supply risk, it has been classified as a critical raw material for the EU and other economies. Part of the EU's strategy is intended to secure its availability, through fostering its efficient use and recycling. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cobalt in end-of-life products in the EU, where does it end up? - The MaTrace approach
  7. 1107
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Realization of the EU's Cohesion Policy in Health Care in the Visegrad Group Countries in the Perspective 2014-2020
  8. 1108
    “…A recent experimental paper demonstrated the MPE in the antiferromagnetic metal EuMnBi(2) at 77 K, but the limited temperature range of the MPE measurement hampered detailed discussion on the MPE. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Large Magneto-piezoelectric Effect in EuMnBi(2) Single Crystal at Low Temperatures
  9. 1109
    por Hackler, Matthias
    Publicado 2020
    “…The EU-China relationship is entering a period of readjustment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Rapprochement amid readjustment: how China sees issues and trends in its changing relationship with the EU
  10. 1110
    “…While policy attention is understandably diverted to COVID-19, the end of the UK's post-Brexit ‘transition period’ remains 31 December 2020. All forms of future EU−UK relationship are worse for health than EU membership, but analysis of the negotiating texts shows some forms are better than others. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Assessing the potential impact on health of the UK's future relationship agreement with the EU: analysis of the negotiating positions
  11. 1111
    “…Some products derived from RNAi plants have received a favourable opinion from the European Food Safety Authority (EFSA) for import and processing in the European Union (EU). The authorization process in the EU requires applicants to produce a risk assessment considering food/feed and environmental safety aspects of living organisms or their derived food and feed products. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Biosafety of GM Crop Plants Expressing dsRNA: Data Requirements and EU Regulatory Considerations
  12. 1112
    “…The photoluminescence emission of the nano-EuO(x) films is tunable as a function of the oxygen concentration changing from a green broadband Eu(2+)-related emission to a narrow red Eu(3+)-related emission. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Photoluminescence and Stoichiometry Correlation in Nanocrystalline EuO(x) Thin Films: Tunable Color Emission
  13. 1113
    por Landesmann, Michael A.
    Publicado 2020
    “…It emphasises that the cumulative nature of the impact of these two crises forces shifts in interest positions of important political actors (countries, sectors, social constituencies) to address issues of ‘systemic instability’ which pushes innovations in the policy instruments that become available at the EU level. Bargaining processes that characterise the negotiations and outcomes of these crisis responses are complex, they reflect differences in size and urgencies to come to agreements, and they have themselves differentiating impacts on relevant political actors.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Covid-19 crisis: centrifugal vs. centripetal forces in the EU—a political-economic analysis
  14. 1114
    “…In 2014, the EU funded a four-year European Cooperation in Science and Technology (COST) Action to address the topic of childbirth. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Understanding childbirth as a complex salutogenic phenomenon: The EU COST BIRTH Action Special Collection
  15. 1115
    “…The emission intensity of La(0.95)Eu(0.05)PO(4) increases more than three times when the Eu(3+) excitation is supported by the localized surface plasmon resonance in the Ag/La(0.95)Eu(0.05)PO(4) nanostructures.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Surface Plasmon Enhancement of Eu(3+) Emission Intensity in LaPO(4)/Ag Nanoparticles
  16. 1116
    por FERRI, Delia
    Publicado 2020
    “…Moreover, this article examines the extent to which EU State aid law has been used to manage and mitigate health risks, by allowing Member States to enhance the preparedness and capacity of their healthcare sector (broadly conceived) to respond to the pandemic. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Role of EU State Aid Law as a “Risk Management Tool” in the COVID-19 Crisis
  17. 1117
    “…PUA-Eu nanowires have longer fluorescence lifetimes than that of Eu complexes and PUA-Eu plates.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Synthesis, Morphology, and Luminescence Properties of Poly(urethane-acrylate) Nanowires Bonding with the Eu(III) Complex
  18. 1118
    por Jorasch, Petra
    Publicado 2020
    “…The results of a survey among 62 private plant breeding companies conducted by Euroseeds and presented in this publication confirm the enormous interest of companies in using new breeding techniques (NBTs) for a wide range of crop species and traits and the negative impact of the current regulatory situation in the EU on companies’ decisions for investments in NBT-related R&D activities for the EU market and beyond.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Potential, Challenges, and Threats for the Application of New Breeding Techniques by the Private Plant Breeding Sector in the EU
  19. 1119
    “…Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the safety of Schizochytrium sp. oil as a novel food (NF) pursuant to Regulation (EU) 2015/2283. Schizochytrium sp. is a single‐cell microalga. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Safety of Schizochytrium sp. oil as a novel food pursuant to Regulation (EU) 2015/2283
  20. 1120
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Gray matter covariations and core symptoms of autism: the EU-AIMS Longitudinal European Autism Project
Herramientas de búsqueda: RSS